Company page

Recordati S.p.a.

Recordati S.p.A. is a public company listed on the Italian stock market under the ticker REC. With a market capitalization of approximately €12.3 billion, Recordati specializes in the development and commercialization of pharmaceuticals. The company focuses on rare diseases and offers a range of innovative treatments to improve patient care.